{{Drugbox
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 7,8-Dimethoxy-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepine
| image = Trepipam structure.png
| width =
<!--Clinical data-->
| tradename = 
| Drugs.com = 
| MedlinePlus =
| licence_US = 
| pregnancy_AU = 
| pregnancy_US = 
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status =
| dependency_liability = 
| routes_of_administration = 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix = 
| ATC_suffix =
| PubChem = 5024
| DrugBank_Ref =
| DrugBank = 
| ChemSpiderID = 4849
| UNII_Ref = 
| UNII = 
| KEGG_Ref = 
| KEGG = 
| ChEBI_Ref = 
| ChEBI = 
| ChEMBL_Ref = 
| ChEMBL = 
<!--Chemical data-->
| C=19 | H=23 | N=1 | O=2
| molecular_weight = 297.39 g/mol
| smiles = CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)OC)OC
|  StdInChI = 1S/C19H23NO2/c1-20-10-9-15-11-18(21-2)19(22-3)12-16(15)17(13-20)14-7-5-4-6-8-14/h4-8,11-12,17H,9-10,13H2,1-3H3
|  StdInChIKey = ICPHJSKVAZMKIV-UHFFFAOYSA-N
}}

'''Trepipam''' ([[International Nonproprietary Name|INN]]) is a [[dopamine receptor]] [[agonist]] of the [[benzazepine]] group that was never marketed.<ref name="Lednicer2009">{{cite book|author=Daniel Lednicer|title=Strategies for Organic Drug Synthesis and Design|url=https://books.google.com/books?id=fEwl6Qev-mUC&pg=PA495|date=4 March 2009|publisher=John Wiley & Sons|isbn=978-0-470-39959-0|pages=495â€“}}</ref>

==References==
{{Reflist}}

{{Dopaminergics}}

[[Category:Benzazepines]]
[[Category:Dopamine agonists]]
[[Category:Abandoned drugs]]

{{drug-stub}}